Tickerplace logo

Tickerplace

BridgeBio Pharma, Inc. logo

BBIOBridgeBio Pharma, Inc.

BBIO Stock Price, Valuation & Chart | BridgeBio Pharma, Inc.

Compare
$66.390-0.74 (-1.10%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

BBIO Historical price chart

BBIO Key Stats

Market Capitalization12.98B
PE Ratio-17.75
EPS-3.74
Trading Volume2.05M
Today's High/Low67.33/65.41
Dividend Yield0.00
52 Week High/Low93.42/52.75
Shares Outstanding195.74M
BBIO Financial Statement
BBIO Analyst ratings
BBIO Analysis & performance metrics

BBIO Company profile

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs…

BBIO Management team

Management
Thomas Trimarchi Ph.D.CFO
Chief Financial Officer & President
Eric Michael David J.D., M.D., Ph.D.CEO
Chief Executive Officer of Gene Therapy
Neil Kumar Ph.D.CEO
Co-Founder, Chief Executive Officer & Director
Richard H. Scheller Ph.D.
Chairman of Research & Development
Matthew Outten CPC, MBA
Chief Commercial Officer
Uma Sinha Ph.D.
Chief Scientific Officer
Maricel M. Apuli
Chief Accounting Officer
Eli M. Wallace Ph.D.
Chief Scientific Officer of Oncology
Total 8 executives

BBIO Frequently asked questions

What is BridgeBio Pharma, Inc. (BBIO) Stock Price?

Current stock price of BridgeBio Pharma, Inc. (BBIO) stock is $66.390. The stock price is -1.10% lower in the session. The intraday range can be seen from this page. Volume of BridgeBio Pharma, Inc. (BBIO) stock is 2.05M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the BridgeBio Pharma, Inc. (BBIO) stock price going up or down today?

The stock price of BridgeBio Pharma, Inc. (BBIO) can change with earnings, company news, and overall market sentiment. BridgeBio Pharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BridgeBio Pharma, Inc. stock expensive at its current price?

Whether BridgeBio Pharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BBIO on this page is -17.75. EPS on this page is -3.74. Compare those figures with peers and growth expectations before deciding if the current BridgeBio Pharma, Inc. price is justified.

How has the stock price of BridgeBio Pharma, Inc. (BBIO) performed historically?

Historical performance for BridgeBio Pharma, Inc. (BBIO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BBIO reacted to past earnings and market events.

Should I buy BridgeBio Pharma, Inc. (BBIO) stock, at this price?

Buying BridgeBio Pharma, Inc. (BBIO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.